ESR1 and breast cancer: Traditionally, there are three clinical subtypes of breast cancer: estrogen or progesterone receptor-positive (ER+ or PR+), human epidermal growth factor receptor 2 positive (HER2+), and triple negative (ER−, PR−, HER2−).